The World Marrow Donor Association Annual Reports describe the current status of the use of unrelated hematopoietic cell products worldwide. In 2008, almost 1.7 million individuals were recruited into unrelated stem cell donor registries and almost 78 000 cord blood units were added to the inventory increasing the total number of available stem cell donors worldwide to over 14 million. In 2008, there were 10 481 adult stem cell donations (3221 BM and 7260 PBSC donations) provided from stem cell donor registries in 38 countries. In 2008, 3529 cord blood products were provided from 21 countries. Although the number of BM donations has been stable over the past 10 years, donations of PBSCs and umbilical cord blood are increasing.
Introduction
The annual reports of the World Marrow Donor Association (WMDA) have become an established instrument to describe the current status of and to observe the trends for the number and types of hematopoietic stem cell products provided worldwide and to monitor the exchange of products between countries. The WMDA has used these data to recommend benchmarks for a standardized practice and to identify barriers to donor exchange. This report describes the trends throughout the 12 years that data have been collected and the results of the WMDA Annual Reports 2008, summarizing the activity as of 1 January 2009.
Data collection
Since 1999, the WMDA has published two reports annually: the Stem Cell Donor Report and the Cord Blood Registries/Banks Report. Stem cell donor registries worldwide are requested to report their data by filling in a questionnaire reporting the number of volunteer donors listed in their database, age and gender of the donors and the number of products provided for unrelated SCT. The project, which started in 1997 with 37 registries, has grown to 71 participating registries in 2008.
Cord blood registries/banks receive a questionnaire asking for the number of cord blood units available, the numbers provided for transplantation, the countries to which cord blood units have been shipped and the degree of matching (A, B serological split level, DRB1 allele). The project started with 19 cord blood registries/banks in 1999 and has grown to 56 cord blood registries/banks (representing 122 cord blood banks) in 2008.
Unrelated adult donors listed worldwide
It is estimated that there are 14.6 million individuals who have volunteered to donate hematopoietic stem cells to any patient in need. In 1997, 37 registries participated in the WMDA annual report from four World Health Organization (WHO) defined regions: 1 from Africa, 8 from the West Pacific, 3 from the Americas and 25 from Europe. The number of participating registries increased to 71 in 2008: 2 from Africa, 9 from the West Pacific, 9 from the Americas, 47 from Europe, 1 from the Eastern Mediterranean and 3 from South East Asia. Figure 1 shows the growth in the number of individuals who have volunteered to serve as hematopoietic stem cell donors in the WHO regions from 1997 through 2008.
The region with the highest percentage of unrelated donors related to its population size is the Americas: 0.73% of the population has volunteered to become a stem cell donor. In contrast, the Eastern Mediterranean region lists only 69 volunteers, 0.000013% of its population. Three countries have a relatively high number of volunteers in relation to the number of inhabitants. In Cyprus, Israel and Germany, 13, 7 and 4%, respectively, of the population have volunteered to become a stem cell donor. In the remaining countries, o1.7% of the population is an adult stem cell donor. In general, a higher Gross National Income (GNI) per person predicts a higher number of listed volunteer adult donors. For countries with a GNI lower than 20 000 United States Dollars, the median ratio of donors listed/GNI is 1.08 compared with countries with a GNI higher than 20 000 United States Dollars in which the median ratio of donors/GNI is 1.41.
Volunteer adult donors are listed in the databases of national stem cell donor registries. The size of these registries varies (Table 1) Figure 2 .
Unrelated adult donors may withdraw from a registry for a variety of reasons including personal and medical reasons. However, the main reason for the withdrawal of adult donors is their age. An adult donor can be active within a registry between 18 years of age until an upper age limit has been reached, usually 55 or 60 years old, depending on local regulations. In 2008, over 60% of the adult donors who were removed from the search files of registries reached the upper age limit. In the next decade, the percentage of donors retiring from registries will increase. This is particularly true for the eight pioneer Nearly all cord blood units (99.4%) are registered in only three WHO regions: 36.5% in the West Pacific region, 35.4% in the Americas and 27.5% in Europe. The size of cord blood registries varies. The largest cord blood registries are located in the United States and Korea. National Marrow Donor Program lists over 90 000 cord blood units followed by Seoul Cord Blood Bank in Korea (over 70 000 cord blood units) and New York Blood Center, United States (over 40 000 cord blood units). However, over 75% of all cord blood registries have an inventory of o10 000 cord blood units (Table 2) . Cord blood banks must continue to collect cord blood units to replace the units used for transplantation. In addition, as standards for acceptable cord blood units have evolved, many stored cord blood units are no longer acceptable. Older units may not have attached segments of blood required for sample testing, may not have been volume depleted or have low cell counts, which make them less likely to be selected by a transplant physician for infusion. Worldwide 77 915 cord blood units were added to the inventory in 2008 (Table 2 ). Figure 4 shows the growth of several pioneer cord blood registries over time. The major growth of the inventory of the 12 pioneer cord blood registries took place between 2001 and 2004 (growth of over 20% annually). Since 2006, the median growth of these cord blood registries has been 10% each year.
Search process and distribution of stem cell products
In 1997, 11 115 searches were initiated for a stem cell donor and 2965 patients received a transplant. In 2008, over 34 000 patient searches were initiated for a stem cell donor and over 20 000 searches for a cord blood product. The stem cell donor registries reported that 9747 patients received a stem cell transplant and 1804 patients received a cord blood transplant in 2008.
The WMDA has realized the importance of facilitating donor selection and has published recommended time frames for registries to comply with the search process. 4 Figure 5 shows a flow diagram of the search process. In 2008, transplant centers requested 55 330 high-resolution HLA typings from donor centers. Sixty-three percent were obtained within the recommended 14 calendar days. In that same period, HLA typing was requested for 8146 cord blood units. In 2008, 97 900 blood samples were requested for shipment to transplant centers. One-third of the blood samples requested were cancelled because of donor-related reasons and 8% for patient-related reasons. Fifty-nine percent of the collected blood samples were sent to the requesting transplant centers within 14 calendar days. In total, 13 507 donor work-ups were requested in 2008. Transplant centers cancelled 2115 of these work-ups. In total, 1320 donors were deferred at work-up, resulting in harvest cancellation of the stem cell collections. Figure 6 shows that the annual number of BM products provided for both national and international patients since 1997 has stabilized at approximately 3200 products each year. Of these, Japan provided 34% because the Japanese adult volunteer donors are only allowed to donate BM and not PBSCs. Other countries providing a large part of the BM products include Germany (23%), United States (21%), United Kingdom (5%) and Italy (3%). The number of PBSC donations is increasing annually, rising from 155 The selection process for cord blood units has changed over time. Two important parameters used to select a cord blood unit are the total nucleated cell count and the degree of HLA matching. Figure 8 provides information regarding the total nucleated cell count of the cord blood units provided for transplantation over time. In 2008, the median total nucleated cell count of all cord blood units provided for children was 136 Â 10 7 compared with units shipped for adult patients of 196 Â 10 7 . The Asian and South American cord blood banks ship smaller units compared with the Australian, European and American cord blood banks. The median total nucleated cell of the Asian cord blood units is 100 Â 10 7 for children (136 Â 10 7 for adult patients), compared with 140 Â 10 7 for children (184 Â 10 7 for adult patients) in the units coming from the United States, Europe or Australia. The second parameter used to select a cord blood unit is the degree of matching. Matching criteria for cord blood products were also included in the WMDA questionnaire. Fifty percent of the cord blood units provided for patients o16 years old have one mismatch (defined at the Ag level for HLA-A, -B and allele level for DRB1). For adult patients, 56% of the cord blood units provided had two mismatches. Over the years, the distribution of the levels of matching has not significantly changed: 10% zero-mismatches, 41%
one-mismatch, 45% two-mismatches and 2% with three or more mismatches.
The number of stem cell products provided for transplantation has increased over time. In Figure 9 , the distribution of BM/PBSC products by continent is shown. In Europe, the number of BM/PBSC products provided each year increased from 1275 in 1997 to 5581 in 2008. The (Figure 11 ). Transplants within Japan only utilized BM and cord blood sources as unrelated products. In the European countries (Germany, The Netherlands, Austria, Switzerland, United Kingdom and Belgium), over 65% of the products utilized for transplantation were PBSC. Cord blood units were major sources of stem cells in France, Spain and Japan representing nearly 40% of the unrelated stem cell products used in these countries. In contrast, o10% of the products used for transplantation in Germany and Austria were cord blood units.
International collaboration
Many patients are unable to find a suitable stem cell donor within their own country's registry. The percentage of products crossing international borders is increasing. Table 3 shows the distribution of stem cell products within Figure 11 The type of stem cell product, BM, PBSC and CBU, used for unrelated transplantation in a specific country, discussed in this paper.
All unrelated stem cell products provided within and to a specific country are counted in 2008. The WMDA was founded to facilitate this extensive international exchange of hematopoietic stem cell products. Through its annual reports, the WMDA continues to monitor this exchange. The data collected are used by the organization to establish guidelines for a standardized practice around the world.
